NICE draft 'no' for Roche's Tecentriq
admin 3rd October 2019 Uncategorised 0The committee felt that comparison to existing treatments for the condition was “unreliable and lacked validity”.
More: NICE draft 'no' for Roche's Tecentriq
Source: News
The committee felt that comparison to existing treatments for the condition was “unreliable and lacked validity”.
More: NICE draft 'no' for Roche's Tecentriq
Source: News
© 1994 - 2026 B.M. Pharmaceuticals